Ultragenyx Pharmaceutical Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2014 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Ultragenyx Pharmaceutical Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2014 to Q2 2024.
  • Ultragenyx Pharmaceutical Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 29, 2024 was 92.2M shares, a 28.9% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 92.2M +20.7M +28.9% Jul 29, 2024 10-Q 2024-08-02
Q1 2024 83.1M +12.3M +17.4% Apr 26, 2024 10-Q 2024-05-03
Q3 2023 82.1M +12M +17.1% Oct 30, 2023 10-Q 2023-11-03
Q2 2023 71.5M +1.45M +2.07% Jul 31, 2023 10-Q 2023-08-04
Q1 2023 70.8M +884K +1.27% May 1, 2023 10-Q 2023-05-05
Q4 2022 70.2M +832K +1.2% Feb 13, 2023 10-K 2023-02-17
Q3 2022 70.1M +1.94M +2.85% Oct 28, 2022 10-Q 2022-11-03
Q2 2022 70M +2.2M +3.24% Jul 25, 2022 10-Q 2022-07-29
Q1 2022 69.9M +2.45M +3.63% May 2, 2022 10-Q 2022-05-06
Q4 2021 69.4M +2.44M +3.64% Feb 10, 2022 10-K 2022-02-15
Q3 2021 68.2M +7.12M +11.7% Oct 28, 2021 10-Q 2021-11-03
Q2 2021 67.8M +7.25M +12% Jul 28, 2021 10-Q 2021-08-03
Q1 2021 67.5M +7.73M +12.9% Apr 30, 2021 10-Q 2021-05-05
Q4 2020 66.9M +9.06M +15.7% Feb 8, 2021 10-K 2021-02-12
Q3 2020 61M +3.27M +5.67% Oct 22, 2020 10-Q 2020-10-27
Q2 2020 60.6M +2.9M +5.02% Jul 27, 2020 10-Q 2020-07-31
Q1 2020 59.7M +2.28M +3.96% May 1, 2020 10-Q 2020-05-07
Q4 2019 57.9M +6.61M +12.9% Feb 10, 2020 10-K 2020-02-14
Q3 2019 57.8M +7.19M +14.2% Oct 31, 2019 10-Q 2019-11-06
Q2 2019 57.7M +7.51M +15% Jul 26, 2019 10-Q 2019-08-02
Q1 2019 57.5M +7.7M +15.5% May 1, 2019 10-Q 2019-05-07
Q4 2018 51.3M Feb 14, 2019 10-K 2019-02-20
Q3 2018 50.6M +7.99M +18.8% Oct 30, 2018 10-Q 2018-11-06
Q2 2018 50.2M +7.72M +18.2% Jul 30, 2018 10-Q 2018-08-03
Q1 2018 49.8M +7.46M +17.6% May 3, 2018 10-Q 2018-05-08
Q3 2017 42.6M +1.73M +4.23% Oct 30, 2017 10-Q 2017-11-03
Q2 2017 42.5M +3.02M +7.67% Jul 24, 2017 10-Q 2017-07-28
Q1 2017 42.3M +3.29M +8.44% May 1, 2017 10-Q 2017-05-05
Q4 2016 41.7M Feb 13, 2017 10-K 2017-02-17
Q3 2016 40.9M +2.03M +5.22% Nov 3, 2016 10-Q 2016-11-08
Q2 2016 39.4M +754K +1.95% Aug 3, 2016 10-Q 2016-08-09
Q1 2016 39M +3.42M +9.62% May 4, 2016 10-Q 2016-05-10
Q3 2015 38.8M +6.94M +21.7% Nov 4, 2015 10-Q 2015-11-10
Q2 2015 38.7M +6.98M +22% Aug 7, 2015 10-Q 2015-08-14
Q1 2015 35.6M +5.56M +18.5% Mar 23, 2015 10-K 2015-03-27
Q3 2014 31.9M Nov 3, 2014 10-Q 2014-11-10
Q2 2014 31.7M Aug 6, 2014 10-Q 2014-08-11
Q1 2014 30M May 7, 2014 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.